0001091818-20-000261.txt : 20201207
0001091818-20-000261.hdr.sgml : 20201207
20201207083650
ACCESSION NUMBER: 0001091818-20-000261
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferguson Merle
CENTRAL INDEX KEY: 0001749860
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51074
FILM NUMBER: 201371440
MAIL ADDRESS:
STREET 1: 1750 BARBARA LANE
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOFORCE NANOSCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001310488
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 852138858
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
BUSINESS PHONE: 757-306-6090
MAIL ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
FORMER COMPANY:
FORMER CONFORMED NAME: SILVER RIVER VENTURES, INC.
DATE OF NAME CHANGE: 20041202
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2020-12-04
2020-12-07
0
0001310488
BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNH
0001749860
Ferguson Merle
1750 BARBARA LANE
ENCINITAS
CA
92024
1
1
1
0
CEO
Common Stock
2020-12-04
4
A
0
11000000
0.001
A
15000000
D
Convertible Preferred 'A'
0.001
2020-12-04
4
M
0
1500000
0.001
A
2020-03-31
2040-03-31
Common Stock
11000000
0
D
On December 4, 2020, BioForce Nanosciences Holdings, Inc. (The "Company" or the "Registrant") issued 11,000,000 shares of its common stock to the reporting individual in exchange for 1,500,000 shares of its Preferred Series 'A' shares. These shares were issued pursuant to an exemption from registration provided by Section 4(2) of the Securities Act of 1933. The issuance was not a public offering as defined in Section4(2)due to the limited number of persons that received the shares, and the matter of the issuances. In addition, the transferee of the common stock represented that they had the necessary investment intent as required by Section 4(2) and agreed to receive shares containing a legend that states the securities were restricted pursuant to Rule 144 of the Securities Act.
This Amended report was done to correct the stock symbol associated with the Company, BioForce Nanosciences Holdings, Inc. The stock symbol is BFNH not BRVO. This filing corrects the stock symbol as being BFNH, item #2 contained in the above information header.
/s/Merle Ferguson
2020-12-07